Volume 30, Number 6
by Tineke Bos, Paul Irving, and Philip Rees
This article presents the benefits of replacing a paper-based production system with Manufacturing Execution System (MES).
by Stephen R. Ferrell
This article discusses how the GAMP 5 quality risk management strategy was applied to an actual case study of a validated Enterprise Resource Planning (ERP) system.
by Rolf Blumenthal
This article focuses on scalability of activities in the life cycle of computerized systems and outlines the level of service standards that pharmaceutical customers can expect from computer system suppliers.
by Catherine Middelberg
Dr. Johannes Roebers provides insight into Elan’s work on current and potential therapies for Alzheimer’s, Parkinson’s, and Multiple Sclerosis and discusses the state of biosimilars today.
by Arthur D. Perez, PhD and Glenn Morton
This article discusses risks and mitigation strategies that need to be considered between healthcare companies and outsourced IT suppliers.
- Discovering the True Value of Membership - GAMP Documents Update - PQLI Update from Brussels: Case Studies in QbD for Biotechnology and Small Molecule Product Realization - Introducing the 2010-2011 Board of Directors - What is the CPIP Certification and What are the Benefits? - Pharmaceutical Engineering Announces Winner of the Article of the Year Award
NOTE: Pharmaceutical Engineering article PDF documents are not to be posted on any Web site, blog site or page, or any other internet site without prior permission from ISPE. (Copyright © ISPE. All rights reserved.)